Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Dec;74(12):1139-49.
doi: 10.1007/s00115-003-1645-8.

[Neurooncology]

[Article in German]
Affiliations

[Neurooncology]

[Article in German]
M Weller. Nervenarzt. 2003 Dec.

Abstract

The central and peripheral nervous systems give rise to a variety of tumors which differ markedly in their incidence, age preference, and prognosis. The nervous system is also frequently affected by metastatic cancer. The major therapeutic options for tumors of the nervous system include surgical resection, radiotherapy using various strategies of fractionation, total dose, and target volume, and different approaches of chemotherapy such as systemic, intrathecal, and interstitial chemotherapy as well as high-dose chemotherapy with stem cell rescue. An increasing number of therapeutic options in neurooncology are no more merely palliative treatments, but may be curative, indicating that neurooncology is experiencing an era both of controversies regarding previous standards of care and of innovative strategies to combat tumors of the nervous system.

PubMed Disclaimer

Similar articles

  • Management of brain metastases.
    Lim LC, Rosenthal MA, Maartens N, Ryan G. Lim LC, et al. Intern Med J. 2004 May;34(5):270-8. doi: 10.1111/j.1444-0903.2004.00579.x. Intern Med J. 2004. PMID: 15151674 Review.
  • Melanoma in the brain: biology and therapeutic options.
    Gibney GT, Forsyth PA, Sondak VK. Gibney GT, et al. Melanoma Res. 2012 Jun;22(3):177-83. doi: 10.1097/CMR.0b013e328352dbef. Melanoma Res. 2012. PMID: 22495668 Review.
  • [ANOCEF guidelines for the management of brain metastases].
    Le Rhun É, Dhermain F, Noël G, Reyns N, Carpentier A, Mandonnet E, Taillibert S, Metellus P; ANOCEF. l’Association des neuro-oncologues d’expression franc¸aise. Le Rhun É, et al. Cancer Radiother. 2015 Feb;19(1):66-71. doi: 10.1016/j.canrad.2014.11.006. Epub 2015 Feb 7. Cancer Radiother. 2015. PMID: 25666314 French.
  • Neurooncology--present and future.
    Grisold W. Grisold W. Onkologie. 2004 Jun;27(3):234-6. doi: 10.1159/000077972. Onkologie. 2004. PMID: 15264332 No abstract available.
  • Treatment of metastatic brain tumors.
    Shibui S. Shibui S. Int J Clin Oncol. 2009 Aug;14(4):273-4. doi: 10.1007/s10147-009-0922-3. Epub 2009 Aug 25. Int J Clin Oncol. 2009. PMID: 19705235 No abstract available.

Cited by

References

    1. N Engl J Med. 2001 Jan 11;344(2):114-23 - PubMed
    1. J Clin Oncol. 1990 Jul;8(7):1277-80 - PubMed
    1. J Clin Oncol. 2003 Sep 1;21(17):3276-84 - PubMed
    1. J Neuropathol Exp Neurol. 2003 Feb;62(2):111-26 - PubMed
    1. J Clin Oncol. 2003 Dec 15;21(24):4489-95 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources